Literature DB >> 15117830

The dystrophin glycoprotein complex: signaling strength and integrity for the sarcolemma.

Karen A Lapidos1, Rahul Kakkar, Elizabeth M McNally.   

Abstract

The dystrophin glycoprotein complex (DGC) is a specialization of cardiac and skeletal muscle membrane. This large multicomponent complex has both mechanical stabilizing and signaling roles in mediating interactions between the cytoskeleton, membrane, and extracellular matrix. Dystrophin, the protein product of the Duchenne and X-linked dilated cardiomyopathy locus, links cytoskeletal and membrane elements. Mutations in additional DGC genes, the sarcoglycans, also lead to cardiomyopathy and muscular dystrophy. Animal models of DGC mutants have shown that destabilization of the DGC leads to membrane fragility and loss of membrane integrity, resulting in degeneration of skeletal muscle and cardiomyocytes. Vascular reactivity is altered in response to primary degeneration in striated myocytes and arises from a vascular smooth muscle cell-extrinsic mechanism.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15117830     DOI: 10.1161/01.RES.0000126574.61061.25

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  161 in total

1.  Inhibition of the IKK/NF-κB pathway by AAV gene transfer improves muscle regeneration in older mdx mice.

Authors:  Y Tang; D P Reay; M N Salay; M Y Mi; P R Clemens; D C Guttridge; P D Robbins; J Huard; B Wang
Journal:  Gene Ther       Date:  2010-08-19       Impact factor: 5.250

2.  Effective regeneration of dystrophic muscle using autologous iPSC-derived progenitors with CRISPR-Cas9 mediated precise correction.

Authors:  Mackenzie Hagan; Muhammad Ashraf; Il-Man Kim; Neal L Weintraub; Yaoliang Tang
Journal:  Med Hypotheses       Date:  2017-11-23       Impact factor: 1.538

3.  Dystrophin Dp71f associates with the beta1-integrin adhesion complex to modulate PC12 cell adhesion.

Authors:  Joel Cerna; Doris Cerecedo; Arturo Ortega; Francisco García-Sierra; Federico Centeno; Efrain Garrido; Dominique Mornet; Bulmaro Cisneros
Journal:  J Mol Biol       Date:  2006-08-01       Impact factor: 5.469

Review 4.  What has the mdx mouse model of Duchenne muscular dystrophy contributed to our understanding of this disease?

Authors:  Jennifer Manning; Dervla O'Malley
Journal:  J Muscle Res Cell Motil       Date:  2015-02-11       Impact factor: 2.698

5.  Expression levels of sarcolemmal membrane repair proteins following prolonged exercise training in mice.

Authors:  Jenna Alloush; Steve R Roof; Eric X Beck; Mark T Ziolo; Noah Weisleder
Journal:  Indian J Biochem Biophys       Date:  2013-10       Impact factor: 1.918

Review 6.  Poloxamer 188 (p188) as a membrane resealing reagent in biomedical applications.

Authors:  Joseph G Moloughney; Noah Weisleder
Journal:  Recent Pat Biotechnol       Date:  2012-12

7.  Thrombospondin expression in myofibers stabilizes muscle membranes.

Authors:  Davy Vanhoutte; Tobias G Schips; Jennifer Q Kwong; Jennifer Davis; Andoria Tjondrokoesoemo; Matthew J Brody; Michelle A Sargent; Onur Kanisicak; Hong Yi; Quan Q Gao; Joseph E Rabinowitz; Talila Volk; Elizabeth M McNally; Jeffery D Molkentin
Journal:  Elife       Date:  2016-09-26       Impact factor: 8.140

Review 8.  Gene therapy in large animal models of muscular dystrophy.

Authors:  Zejing Wang; Jeffrey S Chamberlain; Stephen J Tapscott; Rainer Storb
Journal:  ILAR J       Date:  2009

Review 9.  Vinculin and talin: focus on the myocardium.

Authors:  Alice Zemljic-Harpf; Ana Maria Manso; Robert S Ross
Journal:  J Investig Med       Date:  2009-12       Impact factor: 2.895

10.  Nanotopography-responsive myotube alignment and orientation as a sensitive phenotypic biomarker for Duchenne Muscular Dystrophy.

Authors:  Bin Xu; Alessandro Magli; Yoska Anugrah; Steven J Koester; Rita C R Perlingeiro; Wei Shen
Journal:  Biomaterials       Date:  2018-08-21       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.